{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:15:18Z","timestamp":1791951318947,"version":"4.3.4"},"reference-count":41,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuromuscular Diseases"],"published-print":{"date-parts":[[2024,1,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Despite advances in the medical management of the disease, respiratory involvement remains a significant source of morbidity and mortality in children and adults with Duchenne muscular dystrophy (DMD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The objective of this systematic literature review was to synthesize and grade published evidence of factors associated with respiratory health and function in DMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We searched MEDLINE, Embase, and the Cochrane Library for records of studies published from January 1, 2000 (to ensure relevance to current care practices), up until and including December 31, 2022, reporting evidence of prognostic indicators and predictors of disease progression in DMD. The quality of evidence (i.e., very low to high) was assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The bibliographic search strategy resulted in the inclusion of 29 articles. In total, evidence of 10 factors associated with respiratory health and function in patients with DMD was identified: glucocorticoid exposure (high- to very low-quality evidence), DMD mutations (low-quality evidence), DMD genetic modifiers (low-quality evidence), other pharmacological interventions (i.e., ataluren, eteplirsen, idebenone, and tamoxifen) (moderate- to very low-quality evidence), body mass index and weight (low-quality evidence), and functional ability (low-quality evidence).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In conclusion, we identified a total of 10 factors associated with respiratory health in function in DMD, encompassing both pharmacological therapies, genetic mutations and modifiers, and patient clinical characteristics. Yet, more research is needed to further delineate sources of respiratory heterogeneity, in particular the genotype-phenotype association and the impact of novel DMD therapies in a real-world setting. Our synthesis and grading should be helpful to inform clinical practice and future research of this heavily burdened patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3233\/jnd-230094","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T11:39:48Z","timestamp":1700221188000},"page":"25-57","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Factors Associated with Respiratory Health and Function in Duchenne Muscular Dystrophy: A Systematic Review and Evidence Grading"],"prefix":"10.1177","volume":"11","author":[{"given":"E.","family":"Landfeldt","sequence":"first","affiliation":[{"name":"IQVIA, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aleman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Neurology, Children\u2019s Hospital of Eastern Ontario, Research Institute, University of Ottawa, Ottawa, ON, Canada"},{"name":"Department of Medicine, Division of Neurology, The Ottawa Hospital, Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Abner","sequence":"additional","affiliation":[{"name":"IQVIA, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zhang","sequence":"additional","affiliation":[{"name":"PTC Therapeutics Sweden AB, Askim, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Werner","sequence":"additional","affiliation":[{"name":"PTC Therapeutics Germany GmbH, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Tomazos","sequence":"additional","affiliation":[{"name":"PTC Therapeutics Inc, South Plainfield, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lochm\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Neurology, Children\u2019s Hospital of Eastern Ontario, Research Institute, University of Ottawa, Ottawa, ON, Canada"},{"name":"Department of Medicine, Division of Neurology, The Ottawa Hospital, Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada"},{"name":"Department of Neuropediatrics and Muscle Disorders, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Quinlivan","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Diseases, UCL Institute of Neurology, National Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"ref001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07815-7"},{"key":"ref002","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30025-5"},{"key":"ref003","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201703-0507WS"},{"key":"ref004","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2016.05.016"},{"key":"ref005","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010170"},{"key":"ref006","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"ref007","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265879"},{"key":"ref008","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2011.07.001"},{"key":"ref009","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2018.07.004"},{"key":"ref010","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.12.2103052"},{"key":"ref011","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.09.011"},{"key":"ref012","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000517"},{"key":"ref013","doi-asserted-by":"publisher","DOI":"10.1097\/01.phm.0000184156.98671.d0"},{"key":"ref014","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51046"},{"key":"ref015","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.109601"},{"key":"ref016","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2006.01.010"},{"key":"ref017","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2011.02.016"},{"key":"ref018","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1400"},{"key":"ref019","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318227b164"},{"key":"ref020","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27432"},{"key":"ref021","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23808"},{"key":"ref022","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2007.11.001"},{"key":"ref023","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27662"},{"key":"ref024","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.12.006"},{"key":"ref025","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1200-1"},{"key":"ref026","doi-asserted-by":"publisher","DOI":"10.3233\/JND-180351"},{"key":"ref027","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.05.019"},{"key":"ref028","doi-asserted-by":"publisher","DOI":"10.3233\/JND-170280"},{"key":"ref029","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2016.02.015"},{"key":"ref030","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01418-2017"},{"key":"ref031","doi-asserted-by":"publisher","DOI":"10.3233\/JND-170245"},{"key":"ref032","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2021-0196"},{"key":"ref033","doi-asserted-by":"publisher","DOI":"10.3233\/JND-210665"},{"key":"ref034","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-006-0212-1"},{"key":"ref035","doi-asserted-by":"publisher","DOI":"10.1097\/00131402-200106000-00002"},{"key":"ref036","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)03429-X"},{"key":"ref037","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27427"},{"key":"ref038","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.05.005"},{"key":"ref039","unstructured":"ClinicalTrials.gov. A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids (SIDEROS). Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02814019 (accessed February 12, 2023)."},{"key":"ref040","unstructured":"ClinicalTrials.gov. A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids (SIDEROS). Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03603288 (accessed February 12, 2023)."},{"key":"ref041","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30024-3"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JND-230094","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JND-230094","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JND-230094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:52:34Z","timestamp":1777506754000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JND-230094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,2]]}},"alternative-id":["10.3233\/JND-230094"],"URL":"https:\/\/doi.org\/10.3233\/jnd-230094","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]}}}